Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2025-12-24 @ 2:11 PM
NCT ID:
NCT05530395
Eligibility Criteria:
Inclusion Criteria:
* Metastatic hormone sensitive prostate cancer (mHSPC) patients diagnosed by any imaging test (at least CT and bone scan) including:
* Any newly diagnosed mHSPC with no prior treatments.
* Primarily treated PCa that have progressed to mHSPC with no prior ADT in the last 2 years.
* Patients receiving ADT + EBRT as primary treatment will also be included.
* Patients who agree to be followed prospectively according to routine clinical practice in the context of this study.
Exclusion Criteria:
* Any prior androgen deprivation therapy (ADT) scheme 2 years before recruitment. - Any prior testosterone replacement therapy scheme 2 years before recruitment.
* Previous intermittent ADT schemes.
* Prior testicular excision surgery.
* Absence or testicular atrophy from any cause.
* Whenever further prospective clinical follow-up is not possible or patient do not accept follow-up in the context of this study.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT05530395
Study Brief:
Protocol Section:
NCT05530395